These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11316945)

  • 1. Vascular biology of the isoprostanes.
    Cracowski JL; Devillier P; Durand T; Stanke-Labesque F; Bessard G
    J Vasc Res; 2001; 38(2):93-103. PubMed ID: 11316945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 3: Biomarkers and mediators in vascular physiology and disease].
    Cracowski JL; Berdeaux O; Durand T
    Pathol Biol (Paris); 2005 Jul; 53(6):364-8. PubMed ID: 16004949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The isoprostanes in biology and medicine.
    Praticò D; Lawson JA; Rokach J; FitzGerald GA
    Trends Endocrinol Metab; 2001 Aug; 12(6):243-7. PubMed ID: 11445440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.
    Hou X; Roberts LJ; Taber DF; Morrow JD; Kanai K; Gobeil F; Beauchamp MH; Bernier SG; Lepage G; Varma DR; Chemtob S
    Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R391-400. PubMed ID: 11448840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
    Cracowski JL; Durand T; Bessard G
    Trends Pharmacol Sci; 2002 Aug; 23(8):360-6. PubMed ID: 12377577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury.
    Roberts LJ; Morrow JD
    Ann N Y Acad Sci; 1994 Nov; 744():237-42. PubMed ID: 7825845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoprostanes: novel bioactive products of lipid peroxidation.
    Basu S
    Free Radic Res; 2004 Feb; 38(2):105-22. PubMed ID: 15104204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.
    Bauer J; Ripperger A; Frantz S; Ergün S; Schwedhelm E; Benndorf RA
    Br J Pharmacol; 2014 Jul; 171(13):3115-31. PubMed ID: 24646155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
    Klein T; Neuhaus K; Reutter F; Nüsing RM
    Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].
    Cracowski JL; Stanke-Labesque F; Bessard G
    Rev Med Interne; 2000 Mar; 21(3):304-7. PubMed ID: 10763198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells.
    Yura T; Fukunaga M; Khan R; Nassar GN; Badr KF; Montero A
    Kidney Int; 1999 Aug; 56(2):471-8. PubMed ID: 10432385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive eicosanoids: role of prostaglandin F(2α) and F₂-isoprostanes in inflammation and oxidative stress related pathology.
    Basu S
    Mol Cells; 2010 Nov; 30(5):383-91. PubMed ID: 21113821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of monohydroxyeicosatetraenoic acids and F2-isoprostanes as markers of lipid peroxidation in rat brain mitochondria.
    Wiswedel I; Hirsch D; Nourooz-Zadeh J; Flechsig A; Lück-Lambrecht A; Augustin W
    Free Radic Res; 2002 Jan; 36(1):1-11. PubMed ID: 11999696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isoprostanes, a new substance group in angiology--of future significance?].
    Aghajanian AA; Oguogho A; Sinzinger H
    Vasa; 1997 May; 26(2):65-9. PubMed ID: 9221617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of polyunsaturated fatty acids on vasoconstrictions induced by 8-iso-PGF(2alpha) and 8-iso-PGE(2).
    Sametz W; Jeschek M; Juan H; Wintersteiger R
    Pharmacology; 2000 Apr; 60(3):155-60. PubMed ID: 10754452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature.
    Hou X; Roberts LJ; Gobeil F; Taber D; Kanai K; Abran D; Brault S; Checchin D; Sennlaub F; Lachapelle P; Varma D; Chemtob S
    Free Radic Biol Med; 2004 Jan; 36(2):163-72. PubMed ID: 14744628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo.
    Praticò D
    Atherosclerosis; 1999 Nov; 147(1):1-10. PubMed ID: 10525118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isoprostanes: a putative key role in vascular diseases].
    Cracowski JL
    Rev Med Interne; 2004 Jun; 25(6):459-63. PubMed ID: 15158317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients.
    Basu S
    Toxicology; 2003 Jul; 189(1-2):113-27. PubMed ID: 12821287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.